Maciten Tablet

Maciten Tablet
Product Description

1. Active Ingredient & Strength : Micronized Macitentan 10 mg 2. Indication : Pulmonary arterial hypertension (PAH) 3. Characteristics : - Dual ERA (bosentan + ambrisentan) - Long-term treatment of adult patients with PAH (WHO Group I) corresponding to WHO functional classifications II to III 4. Development Status : BE test completed 5. Dossier : CTD available

Read more Show less

Samjin Pharmaceutical Co., Ltd.

  • KR
  • 2022
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Korea, Republic Of
More specifications Fewer specifications
Sales Markets
Show more Show less

Samjin Pharmaceutical Co., Ltd.

  • KR
  • 2022
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
View company profile

More Products from Samjin Pharmaceutical Co., Ltd. (2)

  • Apixaban Tablet

    Product Apixaban Tablet

    1. Active Ingredient & Strength : Apixaban 2.5 mg, 5 mg 2. Indication : Non-vitamin K antagonist oral anticoagulant (NOAC) 3. Development Status : BE test completed 4. Dossier : Elemental impurities data available
  • Dapagliflozin propanediol hydrate + Sitagliptin (Tablet)

    Product Dapagliflozin propanediol hydrate + Sitagliptin (Tablet)

    1. Active Ingredient & Strength : Dapagliflozin propanediol hydrate + Sitagliptin 100 mg/10 mg 2. Indication : Diabetes 3. Characteristics : - Simplification of 5GLT + DPP-4 co-administration - Small tablet size 4. Development Status : BE test completed